Şunu aradınız:: ieda (Maltaca - İngilizce)

ieda
16.

al ieda
157 annex iii

ieda f' alkaline
carton for zalasta 7.5 mg tablets

Ż ieda ta 'transaminases
hepato-biliary disorders

Ż ieda fil- bilirubin totali
clinically significant weight gain was observed

ieda fil- piżklinikament sinifikanti (≥7%)
clinically significant weight gain (≥ 7%) appears to occur more frequently in the adolescent population compared to adults with comparable exposures.

eridi glikosurja Ż ieda fl- aptit
105 metabolism and nutrition disorders weight gain1

Ż 1 ieda fil- piż livelli għ ta '
eosinophilia

ieda afifa jew moderata fit- tneħija ta '
long-term outcomes associated with these events have not been studied and remain unknown (see sections 4.8 and 5.1).

∫ieda tal-kontribuzzjoni privata b’20%.
reduction of power can be calculated globally at the level of the group of vessels.private contribution increased by 20%.

pazjenti adolexxenti, il- medja taż ieda fil- piż
among adolescent patients, mean weight gain was greatest in patients who were overweight or obese at baseline.

l- olanzapine kienu sonnolenza, ieda fil- pi, eosinofilja,
21 transient asymptomatic elevations of hepatic transaminases (see section 4.4), rash, asthenia, fatigue and oedema.

ieda f’ daqqa tal- livelli tal- glukosju fid- demm.
malfunction or obstruction of the infusion set can result in a rapid rise in glucose levels.

iż ieda medja f' olanzapine auc kienet ta ’ 52% u 108%
the mean increase in olanzapine auc was 52% and 108% respectively.

h`a talbet skuea gåad-dewmien ieda qalet li ma setax jiãi kkunsidrat dewmien sinifikanti.
it otered its apologies for the delays but submimed that they could hardly be considered substantial.

i∆-∆ieda fil-prosperità taƒ-ƒittadini ewropej b’mod sostenibbli titlob:
increasing european citizens’ prosperity in a sustainable way requires:

din i - ieda kienet korrelata mal- livelli totali tal- kon entrazzjoni tal- bilirubin.
the increase correlated with total bilirubin concentrations.

(> 10%) ta 'da, nixfa fil - alq, ieda fl- aptit, u ieda fil- pi.
olanzapine administered with lithium or valproate resulted in increased levels (≥ 10%) of tremor, dry mouth, increased appetite, and weight gain.